239 related articles for article (PubMed ID: 18041590)
21. Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract.
Vicentini C; Fassan M; D'Angelo E; Corbo V; Silvestris N; Nuovo GJ; Scarpa A
Molecules; 2014 Feb; 19(2):2458-68. PubMed ID: 24566314
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 in human neuroendocrine: tumorigenesis.
Chung DC
Ann N Y Acad Sci; 2004 Apr; 1014():209-17. PubMed ID: 15153436
[TBL] [Abstract][Full Text] [Related]
23. [Genomics of neuroendocrine tumors of the lung and gastrointestinal tract: similarities and differences].
Tímár J; Patócs A
Magy Onkol; 2018 Jul; 62(2):77-82. PubMed ID: 30027934
[TBL] [Abstract][Full Text] [Related]
24. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract][Full Text] [Related]
25. The expression of glucagon-like peptide-1 receptor and dipeptidyl peptidase-IV in neuroendocrine neoplasms of the pancreas and gastrointestinal tract.
Wada R; Yagihashi S
Endocr Pathol; 2014 Dec; 25(4):390-6. PubMed ID: 25119061
[TBL] [Abstract][Full Text] [Related]
26. Genetics of neuroendocrine and carcinoid tumours.
Leotlela PD; Jauch A; Holtgreve-Grez H; Thakker RV
Endocr Relat Cancer; 2003 Dec; 10(4):437-50. PubMed ID: 14713256
[TBL] [Abstract][Full Text] [Related]
27. [Genetic profile of gastroenteropancreatic neuroendocrine tumors].
Cabezas Agrícola JM
Endocrinol Nutr; 2009 Apr; 56 Suppl 2():16-9. PubMed ID: 19627765
[TBL] [Abstract][Full Text] [Related]
28. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
29. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue.
Mailman MD; Muscarella P; Schirmer WJ; Ellison EC; O'Dorisio TM; Prior TW
Clin Chem; 1999 Jan; 45(1):29-34. PubMed ID: 9895334
[TBL] [Abstract][Full Text] [Related]
30. [Coexistence of two different neuroendocrine tumors of the upper gastrointestinal tract and of the pancreas].
Ritter MR; Höppner W
Dtsch Med Wochenschr; 1999 Jun; 124(22):712; discussion 713. PubMed ID: 10394354
[No Abstract] [Full Text] [Related]
31. Historical, current and future perspectives on gastrointestinal and pancreatic endocrine tumors.
van Eeden S; Offerhaus GJ
Virchows Arch; 2006 Jan; 448(1):1-6. PubMed ID: 16220293
[TBL] [Abstract][Full Text] [Related]
32. Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors.
Waser B; Rehmann R; Sanchez C; Fourmy D; Reubi JC
J Clin Endocrinol Metab; 2012 Feb; 97(2):482-8. PubMed ID: 22112810
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Toumpanakis CG; Caplin ME
Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
[TBL] [Abstract][Full Text] [Related]
34. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract.
Pizzi S; Azzoni C; Bassi D; Bottarelli L; Milione M; Bordi C
Cancer; 2003 Sep; 98(6):1273-82. PubMed ID: 12973852
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3.
Konukiewitz B; Jesinghaus M; Steiger K; Schlitter AM; Kasajima A; Sipos B; Zamboni G; Weichert W; Pfarr N; Klöppel G
Hum Pathol; 2018 Jul; 77():70-79. PubMed ID: 29596894
[TBL] [Abstract][Full Text] [Related]
36. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
Scarpa A
Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
[TBL] [Abstract][Full Text] [Related]
37. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
[TBL] [Abstract][Full Text] [Related]
38. P53, KI-67, CD117 expression in gastrointestinal and pancreatic neuroendocrine tumours and evaluation of their correlation with clinicopathological and prognostic parameters.
Kımıloğlu Şahan E; Erdoğan N; Ulusoy İ; Samet E; Akyıldız İğdem A; Gönüllü D
Turk J Gastroenterol; 2015 Mar; 26(2):104-11. PubMed ID: 25835106
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
[TBL] [Abstract][Full Text] [Related]
40. [Neuroendocrine tumors of the gastrointestinal-pancreatic system. Classification and diagnosis].
Tiling N; Ricke J; Wiedenmann B
Internist (Berl); 2002 Feb; 43(2):210-8. PubMed ID: 11963758
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]